[#item_full_content]SAN FRANCISCO & TORONTO–(BUSINESS WIRE)–Services financiers Innovation CIBC a fourni du capital de croissance à Landbase,…
Category: Finance
Financial Health, Fintech, Investment, Payments
Why new retirees may need to rethink the 4% rule
[#item_full_content]Investors may need to lower their first-year retirement withdrawals due to lower expectations for long-term stock,…
MicroStrategy gives back earlier gains following bitcoin proxy’s inclusion in Nasdaq-100 index and ‘QQQ’ ETF
[#item_full_content]Shares of MicroStrategy were higher Monday after Nasdaq announced the bitcoin proxy will join the tech-heavy…
MicroStrategy shares jump as bitcoin proxy will join Nasdaq-100 index and ‘QQQ’ ETF
[#item_full_content]Shares of MicroStrategy were higher Monday after Nasdaq announced the bitcoin proxy will join the tech-heavy…
MicroStrategy shares jump as bitcoin proxy will join Nasdaq-100 index and ‘QQQ’ ETF
[#item_full_content]Shares of MicroStrategy were higher Monday after Nasdaq announced the bitcoin proxy will join the tech-heavy…
MicroStrategy shares jump as bitcoin proxy will join Nasdaq-100 index and ‘QQQ’ ETF
[#item_full_content]Shares of MicroStrategy were higher Monday after Nasdaq announced the bitcoin proxy will join the tech-heavy…
MicroStrategy shares jump as bitcoin proxy will join Nasdaq-100 index and ‘QQQ’ ETF
[#item_full_content]Shares of MicroStrategy were higher Monday after Nasdaq announced the bitcoin proxy will join the tech-heavy…
Invesco launches ETF to maximize on the tech concentration craze
[#item_full_content]Invesco launched an exchange-traded fund designed to give investors exposure to the top 45% of companies…
You don’t need to be a ‘Silicon Valley entrepreneur’ to be rich, financial advisor says. Here’s how to retire a millionaire
[#item_full_content]Almost anyone can build a nest egg of $1 million or more, especially if they start…
China ramps up Wall Street meetings as Trump inauguration looms
[#item_full_content]Chinese Vice Premier He Lifeng has met with several U.S. finance executives as Beijing seeks to…
CFPB announces rule limiting bank overdraft fees; trade group sues in response
[#item_full_content]The CFPB says the rule will save American consumers $5 billion annually.
Flushing Financial seeks to raise $70 million to shore up capital as it unloads underwater bonds
[#item_full_content]Banks with commercial real estate exposure have struggled after the Federal Reserve hiked interest rates through…
Trump says he’s not going to make any stock market predictions in case there’s a ‘dip’
[#item_full_content]”I don’t want to get into a situation where they do and we have a dip…
Orthogon Therapeutics cierra una financiación sobresuscrita de USD 5,2 millones para avanzar en el primer tratamiento oral contra el poliomavirus BK
[#item_full_content]CANTON, Mass.–(BUSINESS WIRE)–Orthogon Therapeutics, empresa dedicada al desarrollo de nuevos medicamentos antivirales, anunció hoy el cierre…
Trump says he’s not going to make any stock market predictions in case there’s a ‘dip’
[#item_full_content]”I don’t want to get into a situation where they do and we have a dip…
Riassunto: Orthogon Therapeutics chiude un ciclo di finanziamento da 5,2 milioni di dollari sottoscritto in eccesso per portare avanti la prima terapia orale per il poliomavirus BK
[#item_full_content]CANTON, Massachusetts–(BUSINESS WIRE)–Orthogon Therapeutics, società che sviluppa innovativi farmaci antivirali, oggi ha annunciato la chiusura di…
Orthogon Therapeutics schließt überzeichnete Finanzierung in Höhe von 5,2 Mio. USD ab, um die erste orale Therapie für BK-Polyomavirus voranzutreiben
[#item_full_content]CANTON, Mass.–(BUSINESS WIRE)–Orthogon Therapeutics, ein Entwickler neuartiger antiviraler Medikamente, gab heute den Abschluss einer überzeichneten Finanzierungsrunde…
Orthogon Therapeutics clôture un tour de financement sursouscrit de 5,2 millions USD pour faire progresser la première thérapie orale contre le polyomavirus BK
[#item_full_content]CANTON, Massachusetts–(BUSINESS WIRE)–Orthogon Therapeutics, une société spécialisée dans le développement de nouveaux médicaments antiviraux, a annoncé…
Samenvatting: Orthogon Therapeutics sluit een overtekende financiering van $ 5,2 miljoen af om de eerste orale therapie voor BK-polyomavirus te bevorderen
[#item_full_content]CANTON, Mass.–(BUSINESS WIRE)–Orthogon Therapeutics, een bedrijf voor de ontwikkeling van nieuwe antivirale geneesmiddelen, heeft aangekondigd dat…
オーソゴン・セラピューティクス、BKポリオーマウイルスに対する初の経口治療薬の開発に向け、520万ドルの資金調達を完了
[#item_full_content]マサチューセッツ州カントン–(BUSINESS WIRE)–（ビジネスワイヤ） — オーソゴン・セラピューティクスは本日、新規抗ウイルス薬の開発企業として、目標とした500万ドルを上回る資金調達ラウンドを完了し、総資金調達額が2500万ドルを超えたことを発表しました。この資金調達により、移植患者のBKウイルス再活性化を管理するための、画期的な治療法の開発が加速されます。 同社は、ポリオーマウイルスのライフサイクルに不可欠なウイルスタンパク質を直接標的とする低分子薬を開発することに成功しました。ポリオーマウイルスは、従来の抗ウイルスタンパク質標的を欠いており、数十年間にわたり薬剤開発が困難とされてきました。多様な投資家基盤と独自の作用機序を持つ薬剤のパイプラインに支えられ、オーソゴンは緊急の未充足医療ニーズが満たされていないこの分野に取り組んでいます。 オーソゴン・セラピューティクスの構造生物学担当副社長のスティーブン・ウィークス博士は次のように述べています。「当社の高親和性低分子抗ウイルス薬は、バイオ医薬品の効力に匹敵しながら、その欠点を回避します。この成果は、これまで治療が不